JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(5):220-224

Cytochrome P450 3A polymorphism and its importance in cyclosporine and tacrolimus therapy in transplanted patients

J. Ďuricová, M. Grundmann
Ostravská univerzita, Zdravotně-sociální fakulta, Ústav klinické farmakologie FN, Ostrava

The calcineurin inhibitors cyclosporine (CsA) and tacrolimus (Tac) are widely used in the prevention of acute rejection after solid organ transplantation. However, their clinical use is associated with many adverse reactions. The calcineurin inhibitors CsA and Tac have a narrow therapeutic index and show highly variable pharmacokinetics. The low CsA and Tac bioavailability has been attributed to interindividual differences in the expression of the metabolizing enzyme cytochrome P450 3A. The genes for CYP3A4 and 3A5 undergo genetic polymorphism. The results of many studies focusing on the impact of CYP 3A polymorphism on CsA and Tac pharmacokinetics are clear with Tac, where an association between CYP 3A polymorphism and the pharmacokinetic consequences has been shown. However, the results with CsA are controversial.

Keywords: CYP3A; polymorphism; cyclosporine; tacrolimus; transplantation

Received: July 4, 2007; Accepted: August 23, 2007; Published: May 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ďuricová J, Grundmann M. Cytochrome P450 3A polymorphism and its importance in cyclosporine and tacrolimus therapy in transplanted patients. Čes. slov. farm. 2007;56(5):220-224.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Thervet, E., Legendre, C. H., Beaune, P. et al.: Pharmacogenomics, 2005; 6, 1-11. Go to original source... Go to PubMed...
    2. Waiser, J., Slowinski, T., Brinker-Paschke, A. et al.: Nephrol. Dial. Transplant., 2002; 17, 1310-1317. Go to original source... Go to PubMed...
    3. Staatz, C. H., Taylor, P., Tett, S.: Nephrol. Dial. Transplant., 2001; 16, 1905-1909. Go to original source... Go to PubMed...
    4. Holt, D. W.: Curr Opin. Nephro.l Hypertens., 2002; 11, 657-663. Go to original source... Go to PubMed...
    5. Yu, S. F., Wu, L. H., Zheng, S. S.: Hepatobiliary Pancreat. Dis. Int., 2006; 5, 337-344.
    6. Jorga, A., Holt, D. W., Johnston, A.: Transplant. Proc., 2004; 36, 396-403. Go to original source... Go to PubMed...
    7. Einecke, G., Mai, I., Fritsche, L. et al.: Nephrol. Dial. Transplant., 2004; 19, 215-222. Go to original source... Go to PubMed...
    8. Clase, C. M., Mahalati, K., Kiberd, B. A.: Am. J. Transplant., 2002; 2, 789-795. Go to original source... Go to PubMed...
    9. Undre, N. A., van Hoof, J., Christiaans, Y. et al.: Transplant. Proc., 1999; 31, 296-298. Go to original source... Go to PubMed...
    10. Fredericks, S., Holt, D. W.: Curr. Opin. Nephrol. Hypertens., 2003; 12, 607-613. Go to original source... Go to PubMed...
    11. Utecht, K. N., Hiles, J. J., Kolesar, J.: Am. J. HealthSyst. Pharm., 2006; 63, 2340-2348. Go to original source... Go to PubMed...
    12. Van Schaik, R. H. N., van der Heiden, I. P., van den Anker, J. N. et al.: Clin. Chem., 2002; 48, 1668-1671. Go to original source...
    13. Westlind-Johnsson, A., Hermann, R., Huennemeyer, A. et al.: Clin. Pharmacol. Ther., 2006; 79, 339-349. Go to original source... Go to PubMed...
    14. García-Martín, E., Martínez, C., Pizarro, R. M. et al.: Clin. Pharmacol. Ther., 2002; 71, 196-204. Go to original source... Go to PubMed...
    15. Huang, W., Lin, Y. S., McConn, D. J. et al.: Drug. Metab. Dispos., 2004; 32, 1434-1445. Go to original source... Go to PubMed...
    16. Williams, J. A., Cook, J., Hurst, S. I.: Drug Metab. Dispos., 2003; 31, 1526-1531. Go to original source... Go to PubMed...
    17. Foti, R. S., Fisher, M. B.: Pharmacogenomics. J., 2004; 4, 362-364. Go to original source... Go to PubMed...
    18. Rivory, L. P., Qin, H., Clarke, S. J. et al.: Eur. J. Clin. Pharmacol., 2000; 56, 395-398. Go to original source... Go to PubMed...
    19. Van Ahsen, N., Richter, M., Grupp, C. et al.: Clin. Chem., 2001; 47, 1048-1052. Go to original source...
    20. Hesselink, D. A., van Gelder, T., van Shaik, R. H. N. et al.: Clin. Pharmacol. Ther., 2004; 76, 545-556. Go to original source... Go to PubMed...
    21. Min, D. I., Ellingrod, V. L.: Ther. Drug. Monit., 2003; 25, 305-309. Go to original source... Go to PubMed...
    22. Hesselink, D. A., van Schaik, R. H. N., van der Heiden, P. et al.: Clin. Pharmacol. Ther., 2003; 74, 245-254. Go to original source... Go to PubMed...
    23. Hesselink, D. A., van Gelder, T., Van Shaik, R. H. N.: Pharmacogenomics, 2005; 6, 323-337. Go to original source... Go to PubMed...
    24. Yates, Ch. R., Zhang, W., Song, P. et al.: J. Clin. Pharmacol., 2003; 43, 555-564. Go to original source...
    25. Min, D. I., Ellingrod, V. L., Marsh, S. et al.: Ther. Drug. Monit., 2004; 26, 524-528. Go to original source... Go to PubMed...
    26. Eng, H. S., Mohamed, Z., Calne, R. et al. : Kidney Int., 2006; 69, 1858-1864. Go to original source... Go to PubMed...
    27. Zheng, H. X., Webber, S., Zeevi, A. et al.: Am. J. Transplant., 2003; 3, 477-483. Go to original source... Go to PubMed...
    28. Zheng, H. X., Zeevi, A., Chuetz, E. et al.: J. Clin. Pharmacol., 2004; 44, 135-140. Go to original source... Go to PubMed...
    29. Dai Yang, Hebert, M. F., Isoherranen, N. et al.: Drug Metab. Dispos., 2006; 34, 836-847. Go to original source... Go to PubMed...
    30. Kamdem, L. K., Streit, F., Zanger, U. M. et al.: Clin. Chem., 2005; 51, 1374-1381. Go to original source... Go to PubMed...
    31. MacPhee, I. A. M., Fredericks, S., Tai, T. et al.: Transplantation, 2002; 74, 1486-1489. Go to original source... Go to PubMed...
    32. Tsuchiya, N., Satoh, S., Tada, H. et al.: Transplantation, 2004; 78, 1182-1187. Go to original source... Go to PubMed...
    33. Thervet, E., Anglicheau, D., King, B. et al.: Transplantation, 2003; 76, 1233-1235. Go to original source... Go to PubMed...
    34. Tada, H., Tsuchiya, N., Satoh, S. et al.: Transplant. Proc., 2005; 37, 1730-1732. Go to original source... Go to PubMed...
    35. Mourad, M., Mourad, G., Wallemacq, P. et al.: Transplantation, 2005; 80, 977-984. Go to original source... Go to PubMed...
    36. Choi, J. H., Lee, Y. J., Jang, S. B. et al.: Br. J. Clin. Pharmacol., 2007; 64, 185-191. Go to original source... Go to PubMed...
    37. Zhang, X., Liu, Z. H., Zheng, J. M. et al.: Clin. Transplant., 2005; 19, 638-643. Go to original source... Go to PubMed...
    38. MacPhee, I. A. M., Fredericks, S., Tai, T. et al.: Am. J. Transplant., 2004; 4, 914-919. Go to original source... Go to PubMed...
    39. MacPhee, I. A. M., Fredericks, S., Mohamed, M. et al.: Transplantation, 2005; 79, 499-502. Go to original source... Go to PubMed...
    40. Andrews, P. A., Manoj, S., Chang, R. W. S.: Lancet, 1996; 384, 1446. Go to original source... Go to PubMed...
    41. Zhao, Y., Song, M., Guan, D. et al.: Transplant. Proc., 2005; 37, 178-181. Go to original source... Go to PubMed...
    42. Felipe, C. R., Silva, H. T., Machado, P. G. P. et al.: Clin. Transplant., 2002; 16, 262-272. Go to original source... Go to PubMed...
    43. Vadivel, N., Garg, A., Holt, D. W. et al.: Transplantation, 2007; 83, 997-998. Go to original source... Go to PubMed...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.